Hospital
Dallas County Hospital
Dallas County Hospital was paid $2.41M by Medicaid between Jan 2018 and Nov 2024, across 44 billing codes. Its largest line is 99283, emergency room visit (moderate) — 50% of everything it billed.
33Billing provider infoDALLAS COUNTY HOSPITAL
PERRY, IA 50220
PERRY, IA 50220
33aNPI1669477089assigned 06/14/2005
33bProvider typeCritical Access Hospital
28Total paid$2.41M
24GClaims23,931
24DCodes billed44
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Critical Access Hospital providers in Iowa
Rank by total paid#11 of 79
Median peer was paid$801K
This provider vs. median3.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,700 | $474K | |
| 2019 | 4,341 | $401K | |
| 2020 | 2,129 | $170K | |
| 2021 | 3,322 | $304K | |
| 2022 | 4,562 | $557K | |
| 2023 | 3,864 | $325K | |
| 2024incomplete | 2,013 | $181K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 50% | 7,688 | 6,866 | $1.20M |
| 41899 | Unlisted procedure, dentoalveolar structures | 14% | 167 | 162 | $339K |
| 80053 | Comprehensive metabolic panel | 10% | 4,345 | 3,857 | $252K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 7.3% | 617 | 537 | $175K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.6% | 4,235 | 3,870 | $134K |
| 00170 | Anesthesia for intraoral procedures, including biopsy | 4.8% | 274 | 162 | $115K |
| 36415 | Collection of venous blood by venipuncture | 1.9% | 2,422 | 2,143 | $45K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1.1% | 73 | 65 | $27K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.1% | 528 | 483 | $27K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 472 | 458 | $21K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 270 | 251 | $10K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 138 | 137 | $10K |
32 more codes
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 217 | $8K |
| 85004 | <1% | 521 | $7K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 498 | $5K |
| 86140 | <1% | 248 | $5K | |
| 80061 | Lipid panel | <1% | 80 | $5K |
| 87400 | <1% | 143 | $4K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 74 | $4K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 167 | $3K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 23 | $3K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 17 | $3K |
| 87430 | <1% | 108 | $2K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 29 | $2K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 107 | $1K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 12 | $1K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 87 | $1K |
| J2300 | Injection, nalbuphine hydrochloride, per 10 mg | <1% | 67 | $1K |
| 0011A | <1% | 51 | $963.88 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 15 | $869.60 |
| 82607 | <1% | 12 | $675.48 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 38 | $615.68 |
| 81001 | <1% | 26 | $566.50 | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 13 | $488.63 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 19 | $474.84 |
| 0012A | <1% | 23 | $413.42 | |
| 86756 | <1% | 13 | $303.45 | |
| 81003 | <1% | 17 | $281.82 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 12 | $260.09 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 14 | $244.21 |
| 80306 | <1% | 14 | $230.45 | |
| J3490 | Unclassified drugs | <1% | 12 | $183.70 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 12 | $119.87 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 13 | $108.25 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLOOMIS, RANDY (CFO)